Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joel Becker is CHIEF EXECUTIVE OFFICER at Neuropace. OQRO lists 1 transaction filed with the SEC under this name, the latest on Nov 17, 2026, each linked to the official Form 4.
CHIEF EXECUTIVE OFFICER
Disclosures on record
1
Companies involved
1
As of the latest filing on , Joel Becker reported holding 149,891 shares of Neuropace (NPCE), worth about $1.19M at the last close of $8 (Nov 16, 2026). In the last 12 months, Joel Becker bought $99K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Neuropace NPCE | 149,891 | 150K direct | $8 | $1.19M | Nov 17, 2026 |
Is this Joel Becker’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Joel Becker bought shares on the open market in 2026.
Joel Becker reported 1 open-market purchase and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $99K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
NeuropaceNPCE
Nov 17, 2026Bought~$99K
DetailsOfficial recordJoel Becker reported 1 open-market purchase and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Nov 17, 2026, Joel Becker reported holding 149,891 shares of Neuropace (NPCE). At the last close of $8 on Nov 16, 2026, that is about $1.19M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Joel Becker reported 1 open-market purchase worth $99K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Joel Becker bought shares on the open market in 2026.
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
Neuropace (NPCE), from 2026 to 2026: 1 purchase and 0 sales.